RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development BHFAL Q1 2026 Earnings EPS Miss Overshadowed by Modest Stock Gains TBPH Q1 2026 Earnings Narrower Loss Buoys Investor Sentiment Despite Zero Revenue THRM Q1 2026 Earnings EPS Crushes Estimates with 625 Surprise Tidewater Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines AdvanSix ASIX Q1 2026 Earnings Missed EPS Estimate Amid Challenging Conditions